Added to YB: 2026-02-03
Pitch date: 2026-01-31
CLPT [bullish]
ClearPoint Neuro, Inc.
-8.67%
current return
Author Info
Clinical Catalysts breaks down the science and strategy behind pharma market movers. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$365.6M
Pitch Price
$12.81
Price Target
19.50 (+67%)
Dividend
N/A
EV/EBITDA
-17.88
P/E
-12.07
EV/Sales
9.69
Sector
Health Care Equipment and Supplies
Category
growth
The Overlooked Small-Cap Underpinning Brain Medicine - ClearPoint Neuro, Inc.
CLPT: MRI-guided brain intervention platform enabling precise delivery of gene/cell therapies. $37M FY25 rev (+20% YoY), $54-60M 2026 guidance. 60+ partners, 7K+ procedures create switching costs. REGENXBIO therapy FDA decision Feb 8, 2026. Risk-weighted $19.50 target vs $13 current (~49% upside).
Read full article (7 min)